Drug
Jzp269
Jzp269: highest development phase Phase 1, developed by Jazz Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Jazz Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| JZP269 NCT07813663 | Phase 1 |
Latest
No recent events.
Follow Jzp269 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.